NAUT Historical PE Ratio Notes

— Nautilus Biotechnology (NASDAQ: NAUT) is a life sciences company focused on revolutionizing proteomics through next-generation, single-molecule protein analysis. Its proprietary platform combines innovative instruments, advanced chemistry, & sophisticated machine learning to profile thousands of proteins from small sample sizes hyper-efficiently. By dramatically expanding the ability to quantify & understand the proteins driving human biology, Nautilus aims to accelerate drug discovery, precision medicine, & research breakthroughs. As you review NAUT's historical price, earnings, & PE ratio charts, it's important to recognize that the company is still in a pre-revenue or early commercialization phase. This means consistent earnings are not yet in place, so you'll likely see negative earnings per share (EPS) deeper into its history, often resulting in no meaningful or negative PE ratios (since PE ratio is price divided by earnings). The lack of significant revenue & net profit—common for innovative biotech firms at this stage—can create volatile and sometimes misleading PE ratios until products gain market traction. Investors typically value such companies more by projected future growth than historical earnings, so the conventional PE ratio may not fully capture NAUT's potential during its early years.

On this page we presented the Nautilus Biotechnology Historical PE Ratio information for Nautilus Biotechnology' stock. The average NAUT historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average NAUT historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this NAUT historical PE result, against the recent PE: when this page was posted on 4/16/2026, the most recent closing price for NAUT had been 3.12, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on NAUT or any other given stock, valuation analysis for NAUT can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Nautilus Biotechnology PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NAUT. Thanks for visiting, and the next time you need to research NAUT Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.